MUC1 and non-small cell lung carcinoma: Further analyses showed that MUC1 is significantly upregulated in plasma-derived exosomes of NSCLC patients, and it has been suggested that exosomal MUC1 may be a valuable diagnostic biomarker to distinguish NSCLC patients from healthy individuals.